Skip to search formSkip to main contentSkip to account menu

duloxetine hydrochloride

Known as: Duloxetine Hydrochloride [Chemical/Ingredient], HCl, Duloxetine, Duloxetine HCl 
The hydrochloride salt of duloxetine, a fluoxetine derivative belonging to the class of selective serotonin (5-HT) and norepinephrine (NE) reuptake… 
National Institutes of Health

Related topics

Related topics

19 relations

Broader (4)

AnalgesicsAntidepressive AgentsDopaminergic AgentsSerotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

Narrower (3)

CymbaltaLY 227942LY 248686
In Bloodagonistsanalogs & derivativesantagonists & inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Development of chiral methodologies by capillary electrophoresis with ultraviolet and mass spectrometry detection for duloxetine analysis in pharmaceutical formulations.
2013
2013
Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL/6 mice: Brain region specific changes.
Highly Cited
2011
Highly Cited
2011
Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design
Solid lipid nanoparticles (SLNs) of duloxetine hydrochloride (DLX) were prepared to circumvent the problems of DLX, which include… 
Review
2007
Review
2007
Patterns of depressive symptom response in duloxetine‐treated outpatients with mild, moderate or more severe depression
Aims:  This was a post hoc analysis to determine whether baseline severity of depression influenced the efficacy of duloxetine in… 
2007
2007
Determination of duloxetine in human plasma via LC/MS and subsequent application to a pharmacokinetic study in healthy Chinese volunteers.
2007
2007
Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects.
AIMS To compare single- and multiple-dose duloxetine pharmacokinetics between healthy Japanese and Caucasians. METHODS Twenty… 
Highly Cited
2006
Highly Cited
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
Highly Cited
2006
Highly Cited
2006
Dose–response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder
RationaleThe optimal dose for achieving the maximum antidepressive effect of selective serotonin reuptake inhibitors (SSRIs) or… 
Highly Cited
2005
Highly Cited
2005
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
Clinical consequences of initial duloxetine dosing strategies: Comparison of 30 and 60 mg QD starting doses.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)